An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease
Clinical trial NCT05916157 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05916157
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-30
- Primary completion
- 2027-01-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.